ISSN 2415-3060 (print), ISSN 2522-4972 (online)
  • 32 of 45
УЖМБС 2021, 6(6): 230–238

Influence of Low Concentrations of Carbon Monoxide on Metabolism of Isolated Heart under Conditions of Ischemia-Reperfusion

Beschasnyi S. P., Lysenko Ye. M.

The purpose of the study was to determine the effect of different concentrations of carbon monoxide on the metabolism of isolated mice hearts. Materials and methods. To elucidate the effect of low concentrations of carbon monoxide on the myocardium, we performed retrograde perfusion of isolated hearts of laboratory mice with Krebs-Henseleit solution, which was saturated with carbon monoxide for 5, 10, and 30 minutes. We then determined how different concentrations of carbon monoxide affected coronary volumetric flow rate, myocardial glucose and calcium uptake, creatinine release, and aspartate aminotransferase release. During perfusion, R-wave amplitude and R-R interval were measured using an electrocardiograph. To determine the effect of ischemia on the heart muscle during perfusion with solutions of different concentrations, we measured the area of the affected myocardium after staining with 2,3,5-triphenyltetrazolium chloride. Results and discussion. After these studies, it was found that different concentrations of carbon monoxide had a dose-dependent effect on the isolated mouse heart. However, the dependence of the effects does not follow the pattern «lowest concentration – lowest effect». At the same time, an increase in concentration did not mean an increase in adverse effects on the myocardium. Even on the contrary, the smallest concentration led to increased signs of ischemic myocardial damage. In particular, the use of the solution, through which carbon monoxide was passed for 5 minutes, caused vasoconstrictor effect during perfusion. At the end of reperfusion, vasoconstrictor effect was observed after using a solution through which carbon monoxide was passed for 10 minutes. Increased glucose uptake was observed in the group with 30-minute carbon monoxide permeation against the background of the minimal myocardial creatinine release. In this group there was also a decrease in Ca2+ loss at the beginning of reperfusion (immediately after ischemia). The above phenomenon explains the least degree of ischemic myocardial damage in the isolated mouse heart. The obtained data should be expanded. Since it is difficult to accurately determine the dose of carbon monoxide, then the use of donor compounds is promising. Such compounds include CORM-2 and CORM-3. Under physiological conditions, they decompose in a controlled manner, releasing a specific amount of carbon monoxide. Conclusion. The obtained results indicate that at different concentrations of carbon monoxide can differently influence different structures of cardiomyocyte: at one concentration it binds to calcium channels, other concentrations influence ion channels of plasma membrane, which can explain all these dependencies

Keywords: isolated heart, carbon monoxide, volumetric rate, glucose, creatinine

Full text: PDF (Ukr) 372K

  1. Kukoba TV, Moybenko OO. Hemoksyhenaza ta monooksyd vuhletsyu: zakhyst chy poshkodzhennya klityn? [Hemoxygenase and carbon monoxide: protection or cell damage?]. Fiziol Zh. 2002;48(5):79-92. [Ukrainian]
  2. Motterlini R, Otterbein LE. The therapeutic potential of carbon monoxide. Nat Rev Drug Discov. 2010;9(9):728–743.
  3. Abraham NG, Kappas A. Pharmacological and clinical aspects of heme oxygenase. Pharm Rev. 2008;60:79–127.
  4. Abrahams S, Haylett WL, Johnson G, Carr JA, Bardien S. Antioxidant effects of curcumin in models of neurodegeneration, aging, oxidative and nitrosative stress: A review. Neurosci. 2019;406:1-21.
  5. McDonagh AF. Is bilirubin good for you? Clin Perinatol. 1990;17:359–369.
  6. Marks GS, Brien JF, Nakatsu K, McLaughlin BE. Does carbon monoxide have a physiological function? Trends Pharmacol Sci. 1991;12:185–188.
  7. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN Bilirubin is an antioxidant of possible physiological importance. Science. 1987;235:1043–1046.
  8. Beschasnyi S, Hasiuk O, Shakhman N, Sheldahayeva H. Oxidative stress in athletes after occasional smoking. J Phys Educat Sport. 2021;21(2):942-947.
  9. Lamon BD, Zhang FF, Puri N, Brodsky SV, Goligorsky MS, Nasjletti A. Dual pathways of carbon monoxide-mediated vasoregulation: modulation by redox mechanisms. Circ Res. 2009;105:775–783. PMCid: PMC2771695.
  10. Deniz T, Kandis H, Eroglu O, Gunes H, Saygun M, Kara IH. Carbon monoxide poisoning cases presenting with non-specific symptoms. Toxicol Industrial Health. 2017;33(1):53-60.
  11. Petrova IV, Birulina JG, Trubacheva OA, Belyaeva SN, Shnayder OL, Nosarev AV, et al. Eksperimentalnaya otsenka vliyaniya ekzogennogo monooksida ugleroda na kletki krovi [Experimental estimation of the effects of exogenous carbon monoxide on blood cells]. Bull Siberian Med. 2020;19(1):94-100. [Russian].–100
  12. Motterlini R, Foresti R. Biological signaling by carbon monoxide and carbon monoxide-releasing molecules. Am J Physiol-Cell Physiol. 2017;312(3):C302-C313.
  13. Beschasnyi S, Hasiuk O. CO-releasing molecule (CORM-2) in the regulation of Ca2+-dependent K+-permeability of erythrocyte. Ukr J Med Biol Sport. 2020;2(24): 66-171.
  14. Johnson TE, Wells RJ, Bell A, Nielsen VG, Olver CS. Carbon monoxide releasing molecule enhances coagulation and decreases fibrinolysis in canine plasma exposed to Crotalus viridis venom in vitro and in vivo. Basic Clin Pharmacol Toxicol. 2019;125(4):328-336.
  15. Metere A, Iorio E, Scorza G, Camerini S, Casella M, Crescenzi M, et al. Carbon monoxide signaling in human red blood cells: evidence for pentose phosphate pathway activation and protein deglutathionylation. Antioxid Redox Signal. 2014;20(3):403-416. PMCid: PMC3894680.
  16. Wang R, Wu L. The chemical modification of KCa channels by carbon monoxide in vascular smooth muscle cells. J Biol Chem. 1997;272:8222–8226.
  17. Kotsyuba AYe, Chertok VM, Khramova IA. Vliyaniye sistemy gemoksigenaza-monooksid ugleroda (HO-CO) na reaktivnost' vetvey matochnoy arterii u krys [Effect of the heme oxygenase-carbon monoxide (HO-CO) system on the reactivity of the branches of the uterine artery in rats]. Byull Eksp Biol Med. 2019;167(6):767-771. [Russian]
  18. Sagach VF, Dorofeyeva NA, Drachuk KO. Contribution of hydrogen sulfide to cardio-vascular function restoration in old rats. J Mol Cell Cardiol. 2018;120:35.
  19. Goldstein M. Carbon monoxide poisoning. J Emergency Nurs. 2008;34(6): 538-542.
  20. Hoetzel A, Schmidt R. Carbon monoxide-poison or potential therapeutic? Der Anaesthesist. 2006;55(10):1068-1079.
  21. Kinoshita H, Türkan H, Vucinic S, Naqvi S, Bedair R, Rezaee R, et al. Carbon monoxide poisoning. Toxicol Rep. 2020;7:169-173. PMCID: PMC6992844.
  22. Eichhorn L, Thudium M, Jüttner B. The diagnosis and treatment of carbon monoxide poisoning. Dtsch Arztebl Int. 2018;115(51-52):863. PMCID: PMC6381775.
  23. Kim H, Choi S. Therapeutic aspects of carbon monoxide in cardiovascular disease. Int J Molec Sci. 2018;19(8):2381. PMCID: PMC6121498.
  24. Jeon SB, Sohn CH, Seo DW, Oh BJ, Lim KS, Kang DW, et al. Acute brain lesions on magnetic resonance imaging and delayed neurological sequelae in carbon monoxide poisoning. JAMA Neurol. 2018;75(4):436-443. PMCID: PMC5885203.
  25. Rose J, Nouraie M, Gauthier M, Pizon A, Saul M, Donahoe M, et al. Clinical outcomes and mortality impact of hyperbaric oxygen therapy in patients with carbon monoxide poisoning. Critical Care Med. 2018;46(7):e649. PMCID: PMC6005724.
  26. Tiunov LA, Kustov VV. Toksikologiya okisi ugleroda [Carbon monoxide toxicology]. M: Medicina; 1980. 142 p. [Russian]